Skip to main content
PMC home page
Gut logoLink to Gut
. 1996 May;38(5):775–783. doi: 10.1136/gut.38.5.775

Roles of gall bladder emptying and intestinal transit in the pathogenesis of octreotide induced gall bladder stones.

S H Hussaini 1, S P Pereira 1, M J Veysey 1, C Kennedy 1, P Jenkins 1, G M Murphy 1, J A Wass 1, R H Dowling 1
PMCID: PMC1383164  PMID: 8707128

Abstract

BACKGROUND--Octreotide treatment of acromegalic patients increases the % deoxycholic acid conjugates and the cholesterol saturation of gall bladder bile, and induces gall stone formation. AIMS--To study the roles of gall bladder emptying and intestinal transit in these phenomena. METHODS AND PATIENTS--Gall bladder emptying and mouth to caecum transit was measured in (a) control subjects and acromegalic patients given saline or 50 micrograms of octreotide, and (b) acromegalic patients taking long term octreotide. In the second group, large bowel transit was also measured. RESULTS--A single dose of octreotide inhibited meal stimulated gall bladder emptying, the ejection fraction falling from mean (SEM) 66.0 (2.3)% to 7.0 (5.3)% in controls (p < 0.001); from 72.5 (2.1) to 16.6 (5.1)% in untreated acromegalic patients (p < 0.001), and to 30.4 (9.5)% in acromegalic patients taking long term octreotide (p < 0.001 v untreated acromegalic group). Octreotide prolonged mouth to caecum transit time, from 112 (15) min to 237 (13) min in controls (p < 0.001), from 170 (13) min to 282 (11) min in untreated acromegalic patients (p < 0.001), and to 247 (10) min in acromegalic patients taking long term octreotide (p < 0.001 v untreated acromegalic patients). The mean large bowel transit in octreotide untreated compared with treated acromegalic patients remained unchanged (40 (6) h v 47 (6) h). CONCLUSIONS--Prolongation of intestinal transit and impaired gall bladder emptying may contribute to lithogenic changes in bile composition and gall stone formation in patients receiving long term octreotide.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berr F., Stellaard F., Pratschke E., Paumgartner G. Effects of cholecystectomy on the kinetics of primary and secondary bile acids. J Clin Invest. 1989 May;83(5):1541–1550. doi: 10.1172/JCI114050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bigg-Wither G. W., Ho K. K., Grunstein R. R., Sullivan C. E., Doust B. D. Effects of long term octreotide on gall stone formation and gall bladder function. BMJ. 1992 Jun 20;304(6842):1611–1612. doi: 10.1136/bmj.304.6842.1611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Binmoeller K. F., Dumas R., Harris A. G., Delmont J. P. Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci. 1992 May;37(5):773–777. doi: 10.1007/BF01296438. [DOI] [PubMed] [Google Scholar]
  4. Bond J. H., Jr, Levitt M. D., Prentiss R. Investigation of small bowel transit time in man utilizing pulmonary hydrogen (H2) measurements. J Lab Clin Med. 1975 Apr;85(4):546–555. [PubMed] [Google Scholar]
  5. Carey M. C., Cahalane M. J. Whither biliary sludge? Gastroenterology. 1988 Aug;95(2):508–523. doi: 10.1016/0016-5085(88)90513-6. [DOI] [PubMed] [Google Scholar]
  6. Catnach S. M., Anderson J. V., Fairclough P. D., Trembath R. C., Wilson P. A., Parker E., Besser G. M., Wass J. A. Effect of octreotide on gall stone prevalence and gall bladder motility in acromegaly. Gut. 1993 Feb;34(2):270–273. doi: 10.1136/gut.34.2.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Creutzfeldt W., Lembcke B., Fölsch U. R., Schleser S., Koop I. Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. Am J Med. 1987 May 29;82(5B):49–54. doi: 10.1016/0002-9343(87)90426-8. [DOI] [PubMed] [Google Scholar]
  8. Cullen J. J., Eagon J. C., Dozois E. J., Kelly K. A. Treatment of acute postoperative ileus with octreotide. Am J Surg. 1993 Jan;165(1):113–120. doi: 10.1016/s0002-9610(05)80413-1. [DOI] [PubMed] [Google Scholar]
  9. Dodds W. J., Groh W. J., Darweesh R. M., Lawson T. L., Kishk S. M., Kern M. K. Sonographic measurement of gallbladder volume. AJR Am J Roentgenol. 1985 Nov;145(5):1009–1011. doi: 10.2214/ajr.145.5.1009. [DOI] [PubMed] [Google Scholar]
  10. Dowling R. H., Hussaini S. H., Murphy G. M., Besser G. M., Wass J. A. Gallstones during octreotide therapy. Metabolism. 1992 Sep;41(9 Suppl 2):22–33. doi: 10.1016/0026-0495(92)90027-8. [DOI] [PubMed] [Google Scholar]
  11. Dueno M. I., Bai J. C., Santangelo W. C., Krejs G. J. Effect of somatostatin analog on water and electrolyte transport and transit time in human small bowel. Dig Dis Sci. 1987 Oct;32(10):1092–1096. doi: 10.1007/BF01300194. [DOI] [PubMed] [Google Scholar]
  12. Efendić S., Mattsson O. Effect of somatostatin on intestinal motility. Acta Radiol Diagn (Stockh) 1978;19(2):348–352. doi: 10.1177/028418517801900209. [DOI] [PubMed] [Google Scholar]
  13. Ewins D. L., Javaid A., Coskeran P. B., Shah S., Butler J., Deprez P. H., Miell J., Calam J., Barrett J. J., Dawson J. M. Assessment of gall bladder dynamics, cholecystokinin release and the development of gallstones during octreotide therapy for acromegaly. Q J Med. 1992 Apr;83(300):295–306. [PubMed] [Google Scholar]
  14. Fich A., Camilleri M., Phillips S. F. Effect of age on human gastric and small bowel motility. J Clin Gastroenterol. 1989 Aug;11(4):416–420. doi: 10.1097/00004836-198908000-00014. [DOI] [PubMed] [Google Scholar]
  15. Fuessl H. S., Carolan G., Williams G., Bloom S. R. Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man. Digestion. 1987;36(2):101–107. doi: 10.1159/000199407. [DOI] [PubMed] [Google Scholar]
  16. Guillemin R. Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology. 1976 Dec;99(6):1653–1654. doi: 10.1210/endo-99-6-1653. [DOI] [PubMed] [Google Scholar]
  17. Hepner G. W., Hofmann A. F., Malagelada J. R., Szczepanik P. A., Klein P. D. Increased bacterial degradation of bile acids in cholecystectomized patients. Gastroenterology. 1974 Apr;66(4):556–564. [PubMed] [Google Scholar]
  18. Ho K. Y., Weissberger A. J., Marbach P., Lazarus L. Therapeutic efficacy of the somatostatin analog SMS 201-995 (octreotide) in acromegaly. Effects of dose and frequency and long-term safety. Ann Intern Med. 1990 Feb 1;112(3):173–181. doi: 10.7326/0003-4819-112-3-173. [DOI] [PubMed] [Google Scholar]
  19. Hopman W. P., Van Liessum P. A., Pieters G. F., Jansen J. B., Lamers C. B., Smals A. G., Rosenbusch G., Kloppenborg P. W. Postprandial gallbladder motility and plasma cholecystokinin at regular time intervals after injection of octreotide in acromegalics on long-term treatment. Dig Dis Sci. 1992 Nov;37(11):1685–1690. doi: 10.1007/BF01299859. [DOI] [PubMed] [Google Scholar]
  20. Hostein J., Janssens J., Vantrappen G., Peeters T. L., Vandeweerd M., Leman G. Somatostatin induces ectopic activity fronts of the migrating motor complex via a local intestinal mechanism. Gastroenterology. 1984 Nov;87(5):1004–1008. [PubMed] [Google Scholar]
  21. Hussaini S. H., Murphy G. M., Kennedy C., Besser G. M., Wass J. A., Dowling R. H. The role of bile composition and physical chemistry in the pathogenesis of octreotide-associated gallbladder stones. Gastroenterology. 1994 Nov;107(5):1503–1513. doi: 10.1016/0016-5085(94)90556-8. [DOI] [PubMed] [Google Scholar]
  22. Johansson C., Efendic S., Wisén O., Uvnäs-Wallensten K., Luft R. Effects of short-time somatostatin infusion on the gastric and intestinal propulsion in humans. Scand J Gastroenterol. 1978;13(4):481–483. doi: 10.3109/00365527809181925. [DOI] [PubMed] [Google Scholar]
  23. Johansson C., Wisén O., Efendić S., Uvnäs-Wallensten K. Effects of somatostatin on gastrointestinal propagation and absorption of oral glucose in man. Digestion. 1981;22(3):126–137. doi: 10.1159/000198619. [DOI] [PubMed] [Google Scholar]
  24. Konturek S. J. Somatostatin and gastrointestinal secretion and motility. Adv Exp Med Biol. 1978;106:227–234. doi: 10.1007/978-1-4684-7248-6_30. [DOI] [PubMed] [Google Scholar]
  25. Kullak-Ublick G. A., Paumgartner G., Berr F. Long-term effects of cholecystectomy on bile acid metabolism. Hepatology. 1995 Jan;21(1):41–45. doi: 10.1002/hep.1840210109. [DOI] [PubMed] [Google Scholar]
  26. Kupfer R. M., Heppell M., Haggith J. W., Bateman D. N. Gastric emptying and small-bowel transit rate in the elderly. J Am Geriatr Soc. 1985 May;33(5):340–343. doi: 10.1111/j.1532-5415.1985.tb07134.x. [DOI] [PubMed] [Google Scholar]
  27. Lembcke B., Creutzfeldt W., Schleser S., Ebert R., Shaw C., Koop I. Effect of the somatostatin analogue sandostatin (SMS 201-995) on gastrointestinal, pancreatic and biliary function and hormone release in normal men. Digestion. 1987;36(2):108–124. doi: 10.1159/000199408. [DOI] [PubMed] [Google Scholar]
  28. Macdonald I. A., Bokkenheuser V. D., Winter J., McLernon A. M., Mosbach E. H. Degradation of steroids in the human gut. J Lipid Res. 1983 Jun;24(6):675–700. [PubMed] [Google Scholar]
  29. Marcus S. N., Heaton K. W. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile--three inter-related factors. Gut. 1986 May;27(5):550–558. doi: 10.1136/gut.27.5.550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Metcalf A. M., Phillips S. F., Zinsmeister A. R., MacCarty R. L., Beart R. W., Wolff B. G. Simplified assessment of segmental colonic transit. Gastroenterology. 1987 Jan;92(1):40–47. doi: 10.1016/0016-5085(87)90837-7. [DOI] [PubMed] [Google Scholar]
  31. Mitsukawa T., Takemura J., Nishizono F., Nakatsuru K., Ohgo S., Matsukura S. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans. Am J Gastroenterol. 1989 Nov;84(11):1371–1374. [PubMed] [Google Scholar]
  32. Morris J. S., Low-Beer T. S., Heaton K. W. Bile salt metabolism and the colon. Scand J Gastroenterol. 1973;8(5):425–431. [PubMed] [Google Scholar]
  33. Møller N., Petrany G., Cassidy D., Sheldon W. L., Johnston D. G., Laker M. F. Effects of the somatostatin analogue SMS 201-995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man. Clin Sci (Lond) 1988 Oct;75(4):345–350. doi: 10.1042/cs0750345. [DOI] [PubMed] [Google Scholar]
  34. Nicholl C. G., Polak J. M., Bloom S. R. The hormonal regulation of food intake, digestion, and absorption. Annu Rev Nutr. 1985;5:213–239. doi: 10.1146/annurev.nu.05.070185.001241. [DOI] [PubMed] [Google Scholar]
  35. O'Donnell L. J., Watson A. J., Cameron D., Farthing M. J. Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Pharmacol Ther. 1990 Apr;4(2):177–181. doi: 10.1111/j.1365-2036.1990.tb00463.x. [DOI] [PubMed] [Google Scholar]
  36. Piccione P. R., Holt P. R., Culpepper-Morgan J. A., Paris P., O'Bryan L., Ferdinands L., Kreek M. J. Intestinal dysmotility syndromes in the elderly: measurement of orocecal transit time. Am J Gastroenterol. 1990 Feb;85(2):161–164. [PubMed] [Google Scholar]
  37. Pomare E. W., Heaton K. W. The effect of cholecystectomy on bile salt metabolism. Gut. 1973 Oct;14(10):753–762. [PMC free article] [PubMed] [Google Scholar]
  38. Rhodes M., James R. A., Bird M., Clayton B., Kendall-Taylor P., Lennard T. W. Gallbladder function in acromegalic patients taking long-term octreotide: evidence of rebound hypermotility on cessation of treatment. Scand J Gastroenterol. 1992;27(2):115–118. doi: 10.3109/00365529209165429. [DOI] [PubMed] [Google Scholar]
  39. Richards W. O., Geer R., O'Dorisio T. M., Robarts T., Parish K. L., Rice D., Woltering G., Abumrad N. N. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J Surg Res. 1990 Dec;49(6):483–487. doi: 10.1016/0022-4804(90)90172-x. [DOI] [PubMed] [Google Scholar]
  40. Roda E., Aldini R., Mazzella G., Roda A., Sama C., Festi D., Barbara L. Enterohepatic circulation of bile acids after cholecystectomy. Gut. 1978 Jul;19(7):640–649. doi: 10.1136/gut.19.7.640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Shaffer E. A., Small D. M. Biliary lipid secretion in cholesterol gallstone disease. The effect of cholecystectomy and obesity. J Clin Invest. 1977 May;59(5):828–840. doi: 10.1172/JCI108705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Soudah H. C., Hasler W. L., Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991 Nov 21;325(21):1461–1467. doi: 10.1056/NEJM199111213252102. [DOI] [PubMed] [Google Scholar]
  43. Stolk M. F., van Erpecum K. J., Koppeschaar H. P., de Bruin W. I., Jansen J. B., Lamers C. B., van Berge Henegouwen G. P. Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly. Gut. 1993 Jun;34(6):808–813. doi: 10.1136/gut.34.6.808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Takahashi I., Suzuki T., Aizawa I., Itoh Z. Comparison of gallbladder contractions induced by motilin and cholecystokinin in dogs. Gastroenterology. 1982 Mar;82(3):419–424. [PubMed] [Google Scholar]
  45. Thornton J. R., Heaton K. W. Do colonic bacteria contribute to cholesterol gall-stone formation? Effects of lactulose on bile. Br Med J (Clin Res Ed) 1981 Mar 28;282(6269):1018–1020. doi: 10.1136/bmj.282.6269.1018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Torsoli A., Severi C. The neuroendocrine control of gastrointestinal motor activity. J Physiol Paris. 1993;87(6):367–374. [PubMed] [Google Scholar]
  47. Wald A., Van Thiel D. H., Hoechstetter L., Gavaler J. S., Egler K. M., Verm R., Scott L., Lester R. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology. 1981 Jun;80(6):1497–1500. [PubMed] [Google Scholar]
  48. Wegener M., Börsch G., Schaffstein J., Lüth I., Rickels R., Ricken D. Effect of ageing on the gastro-intestinal transit of a lactulose-supplemented mixed solid-liquid meal in humans. Digestion. 1988;39(1):40–46. doi: 10.1159/000199606. [DOI] [PubMed] [Google Scholar]
  49. Yahiro K., Setoguchi T., Katsuki T. Effect of cecum and appendix on 7 alpha-dehydroxylation and 7 beta-epimerization of chenodeoxycholic acid in the rabbit. J Lipid Res. 1980 Feb;21(2):215–222. [PubMed] [Google Scholar]
  50. Zhu X. F., Shi Y. F., Qin-Dai, Zhang J. X., Harris A. G. Effect of small doses of somatostatin analog, octreotide, on gallbladder contractility in normal Chinese adults. Dig Dis Sci. 1992 Jan;37(1):105–108. doi: 10.1007/BF01308351. [DOI] [PubMed] [Google Scholar]
  51. van Liessum P. A., Hopman W. P., Pieters G. F., Jansen J. B., Smals A. G., Rosenbusch G., Kloppenborg P. W., Lamers C. B. Postprandial gallbladder motility during long term treatment with the long-acting somatostatin analog SMS 201-995 in acromegaly. J Clin Endocrinol Metab. 1989 Sep;69(3):557–562. doi: 10.1210/jcem-69-3-557. [DOI] [PubMed] [Google Scholar]
  52. van der Linden W., Katzenstein B., Nakayama F. The possible carcinogenic effect of cholecystectomy. No postoperative increase in the proportion of secondary bile acids. Cancer. 1983 Oct 1;52(7):1265–1268. doi: 10.1002/1097-0142(19831001)52:7<1265::aid-cncr2820520722>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  53. von der Ohe M. R., Camilleri M., Thomforde G. M., Klee G. G. Differential regional effects of octreotide on human gastrointestinal motor function. Gut. 1995 May;36(5):743–748. doi: 10.1136/gut.36.5.743. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES